Kiniksa has interacted with the U.S. Food and Drug Administration (FDA) and expects to initiate a Phase 2/3 clinical trial of ...

Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is completeTest results support the next development step with Phase 1clinical trial expected ...

Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate ...

Shares of Hims & Hers Health tumbled 18% premarket on Tuesday as Wall Street analysts questioned the telehealth provider's ...

THAI firms grappling with losses of about US$60 million from China’s ban on sugar syrup face shutdowns as soon as next month, ...

BURLINGTON, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...

A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.